Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 34,943 | 35,060 | 31,378 | 26,877 | 26,071 |
| Operating Income | -34,943 | -35,060 | -31,378 | -26,877 | -26,071 |
| Other Income | 2,368 | 1,230 | 718 | 362 | 217 |
| Pre-tax Income | -32,575 | -33,830 | -30,660 | -26,515 | -25,854 |
| Net Income Continuous | -32,575 | -33,830 | -30,660 | -26,515 | -25,854 |
| Net Income | $-32,575 | $-33,830 | $-30,660 | $-26,515 | $-25,854 |
| EPS Basic Total Ops | -0.26 | -0.36 | -0.34 | -0.31 | -0.36 |
| EPS Basic Continuous Ops | -0.26 | -0.36 | -0.34 | -0.31 | -0.36 |
| EPS Diluted Total Ops | -0.26 | -0.36 | -0.34 | -0.31 | -0.36 |
| EPS Diluted Continuous Ops | -0.26 | -0.36 | -0.34 | -0.31 | -0.36 |
| EBITDA(a) | $-35,635 | $-35,196 | $-31,154 | $-26,649 | $-25,829 |